Anthem Biosciences Soars 27% on Stellar IPO Debut

Anthem Biosciences, founded in 2006 and headquartered in Bengaluru, is one of India’s leading Contract Research, Development, and Manufacturing Organizations (CRDMO). With a global footprint across 44+ countries and over 550 clients, the company offers end-to-end pharmaceutical services—from early-stage drug discovery to commercial manufacturing.

  • Anthem operates across both small and large molecule domains, serving biotech startups and pharma giants alike. Their offerings include””
  • Fermentation-based APIs: Probiotics, enzymes, peptides, and vitamin analogues
  • Specialty Ingredients: Nutritional actives, biosimilars, and high-potency compounds
  • Drug Discovery & Development: Clone development, preclinical studies, and GMP manufacturing
  • Integrated Services: From target identification to Phase III trials and regulatory filings


Scroll to Top